MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-16-0002188
Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals Private Limited - chemicals in Basti, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.77 Lakh
▲ 130% YoY
Net profit · FY 2024
₹14,222
Net margin 1.5%
EBITDA · FY 2024
₹19,219
EBITDA margin 2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Indorbit Pharmaceuticals Private Limited
Data last updated:
Indorbit Pharmaceuticals Private Limited is a private limited company based in Basti, Uttar Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 24 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2021PTC146492. Its GSTIN is 09AAGCI1545M1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vivek Kumar Sharma and Amit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 106 Ground Floor Basti Nagar Road Kushmaur, Uttar Pradesh, India – 272001.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.77 Lakh, a growth of 130% compared to the previous year. For the same year it recorded a net profit of ₹14,222 (net margin 1.5%) and EBITDA of ₹19,219 (EBITDA margin 2%).
Court records list 1 case involving the company, including 1 filed against it.
Indorbit Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-16-0002188).
Company Details of Indorbit Pharmaceuticals Private Limited
CIN U24299UP2021PTC146492
Registration Number 146492
Incorporation Date 24 May 2021
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-UP-16-0002188
Recognitions & Rankings of Indorbit Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address106 Ground Floor Basti Nagar Road Kushmaur, Uttar Pradesh, India – 272001
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Indorbit Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Indorbit Pharmaceuticals Private Limited
The main business activity of Indorbit Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Indorbit Pharmaceuticals Private Limited FY 2024 filings available
Indorbit Pharmaceuticals Private Limited reported revenue of ₹9.77 Lakh (up 130% YoY) for FY 2024.
Revenue · FY 2024
₹9.77 Lakh ▲ 130%
Net profit · FY 2024
₹14,222 margin 1.5%
EBITDA · FY 2024
₹19,219 margin 2%
Compounded Annual Growth Rate (CAGR) of Indorbit Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 130%
EBITDA CAGR growth
1 year
▲ 241%
Revenue rose 130% in the latest year. EBITDA rose 241% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Indorbit Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹19,219 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14,222 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Indorbit Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2% | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indorbit Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Kumar Sharma Also directs: Pluscure Pharmaceutical Private Limited | Director | 24 May 2021 | 5 Years 4 Months | Current |
| Amit Sharma | Director | 19 Apr 2023 | 3 Years 6 Months | Current |
| Nishant Singh | Director | 22 Jul 2024 | 2 Years 2 Months | Current |
| Punj Prakash Mishra Also directs: Narayani Multispeciality Hospital LLP | Director | 01 Aug 2024 | 2 Years 2 Months | Current |
Peer Comparison of Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syan Pharmaceuticals Private Limited | ₹9.81 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Jehanabad, Bihar, India |
| Maclave Pharmaceuticals Private Limited | ₹9.78 Lakh (FY 2024) | •••• | •••• | 24.0% | •••• | Etawah, Uttar Pradesh, India |
| Grecian Pharmaceuticals Private Limited | ₹9.77 Lakh (FY 2016) | •••• | •••• | •••• | Bhubaneswar, Odisha, India | |
| Anuriuswell Pharmaceuticals Priavte Limited | ₹9.77 Lakh (FY 2020) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Dweps Pharmaceuticals Private Limited | ₹9.77 Lakh (FY 2024) | •••• | •••• | 413.0% | •••• | Jamshedpur, Jharkhand, India |
| Indorbit Pharmaceuticals Private Limited this company | ₹9.77 Lakh (FY 2024) | •••• | •••• | 130.0% | •••• | Basti, Uttar Pradesh, India |
| Tempest Pharmaceuticals Private Limited | ₹9.73 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Kolkata, West Bengal, India |
| Yagmi Pharmaceuticals Private Limited | ₹9.73 Lakh (FY 2019) | •••• | •••• | 1956.0% | •••• | Lucknow, Uttar Pradesh, India |
| Giramsan Pharmaceuticals Private Limited | ₹9.73 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Sagar, Madhya Pradesh, India |
| Prophine Pharmaceuticals Private Limited | ₹9.72 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Morena, Madhya Pradesh, India |
| Andheri Pharmaceuticals Pvt Ltd | ₹9.72 Lakh (FY 2020) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Indorbit Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Indorbit Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 28 Sep 2026.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Torrent Pharmaceuticals Ltd | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals Private Limited has 6 board changes on record since 2021: 5 appointments and 1 cessation. The latest: Punj Prakash Mishra was appointed as Director on 01 Aug 2024.
AGM
Indorbit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Punj Prakash Mishra was appointed as Director.
Appointed
Nishant Singh was appointed as Director.
Filing
Indorbit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttar Pradesh I.
Ceased
Ravi Kant Dubey ceased to be Director.
Appointed
Amit Sharma was appointed as Director.
Appointed
Ravi Kant Dubey was appointed as Director.
Appointed
Vivek Kumar Sharma was appointed as Director.
Incorporation
24 May 2021
Indorbit Pharmaceuticals Private Limited was registered on 24 May 2021 with Roc Uttar Pradesh I & aged 5 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Indorbit Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indorbit Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indorbit Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCI1545M1Z9 | Uttar Pradesh | Active | 11 Aug 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indorbit Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indorbit Pharmaceuticals Private Limited
Indorbit Pharmaceuticals is an active private limited company based in Basti, Uttar Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 24 May 2021 (5+ years old) and is registered under CIN U24299UP2021PTC146492.
Indorbit Pharmaceuticals reported revenue of ₹9.77 Lakh for FY 2024 (up 130% YoY).
Indorbit Pharmaceuticals has 4 current directors:
- Vivek Kumar Sharma - Director
- Amit Sharma - Director
- Nishant Singh - Director
- Punj Prakash Mishra - Director
Indorbit Pharmaceuticals reported a net profit of ₹14,222 (net margin 1.5%) and EBITDA of ₹19,219 (EBITDA margin 2%) for FY 2024, as per its filed financial statements.
The GSTIN of Indorbit Pharmaceuticals is 09AAGCI1545M1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Indorbit Pharmaceuticals is U24299UP2021PTC146492. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indorbit Pharmaceuticals has 1 court case on record: 1 filed against it.
Indorbit Pharmaceuticals was incorporated on 24 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Indorbit Pharmaceuticals by revenue are Syan Pharmaceuticals Private Limited, Maclave Pharmaceuticals Private Limited, Grecian Pharmaceuticals Private Limited, Anuriuswell Pharmaceuticals Priavte Limited, Dweps Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Punj Prakash Mishra was appointed as Director on 01 Aug 2024. Nishant Singh was appointed as Director on 22 Jul 2024. Ravi Kant Dubey ceased to be Director on 21 Apr 2023. Indorbit Pharmaceuticals has 6 board changes on record in total.
Yes, Indorbit Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-16-0002188).